Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.68
+0.36 (2.08%)
At close: Jan 31, 2025, 4:00 PM
17.50
-0.18 (-1.02%)
After-hours: Jan 31, 2025, 6:39 PM EST
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 30 employees as of December 31, 2023. The number of employees increased by 2 or 7.14% compared to the previous year.
Employees
30
Change (1Y)
2
Growth (1Y)
7.14%
Revenue / Employee
$1,155,900
Profits / Employee
-$182,700
Market Cap
456.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ETON News
- 4 weeks ago - Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin® - GlobeNewsWire
- 6 weeks ago - Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - GlobeNewsWire
- 4 months ago - Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen - GlobeNewsWire